LBF20000PG02
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1708 |
LipidMaps | LMFA03010145 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20000PG02 |
13,14-dihydro-15keto Prostaglandin E1 | |
---|---|
Structural Information | |
9,15-dioxo-11α-hydroxy-prostan-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CCC(=O)CC[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
13,14-dihydro-15keto PGE1 is a metabolite of PGE1. Hamberg_M et al. Leonhardt_A et al. | |
13,14-dihydro-15keto PGE1 is a week inhibitor of ADP-induced platelet aggregation in human PRP. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|